#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alagille syndrome Stiff person syndrome Biotinidase deficiency Oesophageal atresia Extra-osseous Ewing's sarcoma metastatic Follicular lymphoma Microvillous inclusion disease Heritable pulmonary arterial hypertension Trigeminal neuralgia Hereditary ataxia Intracranial calcification Leukoencephalopathy Thalassaemia alpha Retinitis pigmentosa Fallopian tube cancer More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Basic Information Nephrotic syndrome – Trials in Disease Mucopolysaccharidosis I – Diagnostics CADASIL – Diagnostics Andersen-Tawil syndrome – Trials in Disease Alexander disease – Life with Disease Small intestine leiomyosarcoma – Diagnostics Pituitary-dependent Cushing’s syndrome Paraneoplastic neurological syndrome – Trials in Disease Cystic fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IDOR-1117-2520C Amikacin Sulfate Vutrisiran Lolium Perenne Daunorubicin Hydrochloride Nintedanib Vepdegestrant Ly3819469 Sodium IMB 101 Fluticasone Propionate Cldn6 Rna-Lpx Tas3351 UDONITRECTAG CITRIC ACID ANHYDROUS Pamidronate Disodium Msv-Allo Padeliporfin Obinutuzumab Crizotinib Clobetasol Propionate More therapies…

    Learn about Your Condition

    Relapsing multiple sclerosis Peripheral artery angioplasty Vomiting Short-bowel syndrome Lichen planus Atopic keratoconjunctivitis Thyroid disorder Dyspepsia Constipation B-cell lymphoma recurrent Haemorrhoids Primary biliary cholangitis Pleural mesothelioma malignant Endometrial cancer stage IV Infant sedation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Rheumatic disorder

  • Study of Janus kinase inhibitor dose reduction in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis who have achieved low disease activity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    • Rheumatic disorder
    • Psoriatic arthropathy
    Investigated Drugs:
    • Filgotinib
    • Tofacitinib
    • Upadacitinib
    The Netherlands

  • Study on Immune Response to Recombinant Zoster Vaccine in Rheumatic Disease Patients Using Baricitinib, Tofacitinib, or Methotrexate

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatic disorder
    Investigated Drugs:
    • Recombinant Varicella Zoster Virus Glycoprotein E
    • Filgotinib
    • Tofacitinib
    France

  • Study to Test if Nerandomilast (BI 1015550) Helps Patients with Interstitial Lung Disease Related to Rheumatic Diseases

    Recruiting

    3 1
    Investigated Diseases:
    • Rheumatic disorder
    • Interstitial lung disease
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria France Germany Italy The Netherlands Norway +1

  • Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    • Rheumatic disorder
    Investigated Drugs:
    • Vedolizumab
    • Atezolizumab
    • Bevacizumab
    The Netherlands

  • Study of cardiovascular disease prevention using carotid ultrasound in patients with inflammatory rheumatic diseases treated with amlodipine, atorvastatin, rosuvastatin, ezetimibe and bempedoic acid

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatic disorder
    Investigated Drugs:
    • Amlodipine
    • Rosuvastatin Calcium
    • Bempedoic Acid
    Spain

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!